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868 Stroke Prevention: Newer Devices in 
intervention Stenting for Peripheral 
Vascular Disease 
Wednesday, April 02, 2003, 8:30 a.m.-10:OO a.m. 
McCormick Place. Room S105 
8:30 a.m. 
868-i Percutaneous Left Atrial Appendage Transcatheter 
Occlusion (PLAATO ) to Prevent Stroke in Patients 
With Atriai Fibrillation: initial Results of the Multicenter 
Feasibility Trial 
Horst Sievelt, Michael D. Lesh. Stefan Ostermayer, Kai Billinger, Thomas Trepels, 
Heyder Omran, Antonio L. ??artorelli, Paolo Della Bella, Toshiko Nakai, Mark Reisman, 
William Gray, Carlo DiMario, Peter C. Block, Paul Kramer, David 0. Williams, Athena 
Poppas, Allan Skanes. Ulrike Krumsdorf, Detlef Scherer, Cardiovascular Center 
Bethanien, Frankiurt. Germany, Univ. of California, San Francisco, CA 
Background: Thromboembolism due to atrial fibrillation (AF) is a frequent cause of 
stroke. More than 90 % of thrombi in AF form in the LAA. Catheter closure of the LAA 
might prevent stroke in AF. In this multicenter trial 52 pts with AF (age=70 f 7 yrs; MI 
F&!/20) and additional risk factors for stroke who were sub-optimal candidates for war- 
farin were enrolled. 
Methods: The PLAATO system consists of a self-expanding cage covered with ePTFE 
delivered through a 12Fr transseptal sheath specially designed to access the LAA. It is 
retrievable before release and can be replaced with an alternate size to optimize sealing. 
Results: Device implanta8on (diameters 18.32mm) was successful in all pts, in one dur- 
ing a second procedure. Angiography and transesophageal echocardiography during the 
procedure showed that the device was well-seated in all patients. Hemopericardium 
occurred in 3 (pericardiocentesis performed without sequelae) but all had successful 
implantation, esophageal bleeding due lo TEE in 1. No migration, mobile thrombus or 
interference with cardiac structures was noted on TEE performed 1 and 8 mos post pro- 
cedure. In 1 pt. a laminar echogenic layer representing possible thrombus was noted on 
the implant surface at 1 and 8 mos. No clinical events have occurred in this pt. During fol- 
low up (median 4.5 mo) one pt died 7 mo post implant. He had a history of diffuse athero- 
sclerotic vascular disease and multiple prior strokes. TEE performed 2 weeks prior to 
death showed the device well positioned with no thrombus. 
Conclusions: Transcatheter closure of the LAA with a novel implanted device is feasi- 
ble, and safe during short term follow up. Longer term studies will be needed to show that 
this technology reduces stroke in pts with AF who are sub-optimal candidates for antico- 
agulation. 
8:45 a.m. 
868-2 Outcomes From Carotid Artery Stenting in Over 1,000 
Cases From a Single Group of Operators 
Gishel New Gary S. Roubin, Sriram S. lyer, George Dangas, Roxana Mehran, Yuliya G. -I 
Adamyan, Thosaphol Limpijankit, Christina Brennan, Palawi Kumar, Jiri J. Vitek, Lenox 
Hill Heart and Vascular Institute, Cardiovascular Research Foundation, New York, NY 
Background: We repori the 8year experience of a single group of operators in over 
1000 carotid stenting (CS) procedures. 
Methods: Patients were enrolled and prospectively followed from September 1994 until 
August 2002. Neuroprotection devices were introduced in January 2000. Patient demo- 
graphics, procedural details, 30-day events and long-term follow up data were collected. 
Results were also annualized to determine if there was an improvement over time in peri- 
procedural results. 
Results: 1068 patients underwent CS of 1202 arteries. The mean age of the patients 
was 71 f 10 years. 34% were female with 15% of patients were >80 years of age. 60% of 
patients had concomitant CAD. 10% had contralateral occlusions and 17% had a history 
of prior carotid endarterectomy. Procedural success was achieved in 99% of cases. 33% 
of patients had their procedure performed using a neuroprotection device. Data annual- 
ized in the table below shows a significant reduction in stroke over the 8-year time-period 
(Chi-Square for Trend Analysis). The only multivariate predictors of stroke were hyper- 
tension (p < 0.05). age > 80 yrs (p < 0.05) and symptomatic status (p < 0.05). 
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Conclusion: Improvements in technique, equipment, pharmacotherapy and the use of 
g 
neuroprotection have contributed to the dramatic decline in event rates in the more 0 
recent years of this study. Stroke rates from carotid stenting have declined to levels com- 5 
parable or better than randomized surgical trials. 
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888-3 
Zivad M. Hiiazi David Balzer. Carlos Ruiz, Michael Vance, John Bass, Mary Heitschmidf 
University of Chicago, Chicago, IL, Washington University School of Medicine, St. Louis, L 
MO 
Transcatheter Closure of Post-infarct Ventricular Septai 
Defects: immediate and Mid-Term Results of U.S. 
Registry Using the Amplatzer Post-Infarct Ventricular 
Septai Defect Occiuder 
Background: Post infarction rupture of the ventricular septum carries a grave prognosis. 
Surgical closure of such defects is associated with very high mortality and morbidity. 
Recent advances in device technology may potentially replace surgical closure in these 
patients. We report the initial and mid-term results of a US registry using the Amplaizer 
post-infarct VSD occluder. 
Methods: Ten patients (7female) with post infarct ventricular septal defects (PIVSD) 
underwent an attempt of closure of their defects at a median age of 73 yr. (range 52-86 
yr.). The median size of VSD as measured by echocardiographylangiography was 13.5 
mm (range 8-18 mm). Six patients had prior unsuccessful surgical intervention for the 
VSD. The procedure was performed under general endotracheal anesthesia in 7. 
Results: All patients tolerated the catheterization procedure. Devices were deployed from 
the right internal jugular vein in 8 patients and from femoral vein in two. The sizes of 
devices deployed ranged from 12-22 mm. In 9 patients the attempt was successful in 
deploying the devices and in one the device could not be secured across the VSD. The 
median fluoroscopy time was 36 minutes (15-63 minutes) and the median total proce- 
dure time was 131 minutes (range 76-229 minutes). Immediately after the procedure, the 
shunt disappeared completely in 1; 3 had trivial shunt and in 4 the shunt was small. Com- 
plications encountered during or after the procedure included hematoma requiring trans- 
fusion in one; pacemaker for pre-existent sinus node dysfunction in one and 
tracheaostomy for ventilator dependence in one. At a follow-up interval of &months, five 
patients are alive and doing well. Conclusion: Catheter closure of PIVSD using the 
Amplatzer device is safe and effective. Further clinical trials are underway. 
9:15 a.m. 
868-4 Nitinoi Stent Fractures in the Superficial Femoral 
Artery: incidence and Clinical Significance 
Krishna J. Rocha-Sinqh, Karen Scheer. Janiece Rutherford, Prairie Heart Institution, 
Springfield, IL 
Background: Nitinol stems combine the advantages of excellent radial strength and 
scaffolding with non-compressibility and minimal foreshortening. Originally designed for 
use in the carotid artery, nitinol stents are increasingly being used to treat suboptimal/ 
failed percutaneous transluminal angioplasty (PTA) results in the superficial femoral 
artery (SFA). However, preliminary six month angiographic follow-up in a small cohort of 
SFA nitinol stent patients has recently revealed the unexcepted and previously unre- 
ported finding of stem strut fractures. The incidence and clinical significance of nitinol 
stent fractures in the SFA is unknown. 
Methods: We retrospectively identified 78 patients (84 limbs, 92 lesions) in which 105 
nitinol stems were implanted between January 1999 and November 2001 after subopti- 
mallfailed PTA for severe claudication (93%) or critical limb ischemia. To date, 14 
patients have returned for fluoroscopic assessment of the nitinol stem skeleton: 10 
patients received 15 SMARTTM stents, five received six DynaLinkTM stems, and one 
received one MemothermTM stent. All 14 patients had SFA color duplex-doppler assess- 
ment at the time of fluoroscopic follow-up to assess stent patency. The mean follow-up 
was 18.4 * 9.8 mos. post-procedure (range Smos. to 43 mos). 
Results: All stem procedures were successful; no patient experienced abrupt or sub- 
acute stent closure. No patient required percutaneous or surgical revascularization of the 
index extremity at follow-up. Three of the 22 stents evaluated (13.6%) had fluoroscopic 
evidence of stent strut fractures resulting in stem deformation; one of the three stems 
met duplex doppler criteria for restenosis.The overall stent restenosis rate in the 14 
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patients was 14%. There was no evidence of stent migration. 
Conclusion: We observed strut fractures in 13.6% of the nitinol SFA stents at 18 mos. 
mean follow-up. Restenosis defined by arterial duplex doppler occurred in 14% of all 
StentS and in 7% of fractured stents. Fluoroscopic and arterial duplex-doppler follow-up 
of the entire 76 patient cohort (105 stems) is ongoing. Presently, the clinical significance 
of the observed stent fractures is uncertain. 
ORAL CONTRIBUTIONS 
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868-5 Long-Term Outcome of Superficial Femoral Artery 
Stenting Using Self-Expandable Nitinol Stents 
Compared to Stainless Steel Stents: A Retrospective 
Multicenter Study 
Bibi Fatemeh Haverizadeh, Thomas Zeller, Hans Krankenberg, Dierk Scheinerl, Aljosha 
Rastan, Sven BrBunlich, Andrej Schmidt, Sylvia Geier. Susanne Ropers, Giancarlo 
Biamino, Herzzentrum Leipzig, Leipzig, Germany, Center for Cardiology, Angiology and 
Vascular Interventions, Hamburg, Germany 
Background: With the aim lo establish the long-term value of stenting long superiicial 
femoral artery (SFA) lesions, the data of four German high-volume centers were retro- 
spectively evaluated. 
Methods: Among consecutive SFA stenting procuedures in our centers during 1999- 
2000, 163 SFA stenting procedures using self-expanding nitinol stent (SMART stent, 
Cordis; Group S) were compared with 166 implantation procuedures using self-expand- 
able stainless steel stent (W&tent, Boston Scientific)in the same time window (Group 
W). Patients with in-stent stenting and multiple stent types in the same vessel were 
excluded. 
Results: Patients’ mean age was 66.5+/-10.1 and 32% were females wthout statistically 
significant difference between the two groups. Diabetics included 21% of the S group 
comparing 40% in the W group (p: 0.001). Clinical symptoms based on Rutherford crite- 
na were: (II: S: 19% vs W: lo%, Ill: S:72% vs W:77%, IV: S:5% vs W:lO%, V: S:3% vs 
W:3%; p: NS ). 16% of the Smart group had previous target lesion angioplasty comparing 
23% in the wallstent group (p: NS). There was no difference between the two groups 
comparing lesion length (S: 176+/-110 vs W: 197+/-101 mm p:NS), percent stenosis (S: 
97.9+/-4.6 vs W: 97.2+/-9.9 %) and number of stents (S&W: 1.6+/-l .O). Overall stented 
length was longer in the wallstent group (S: 120+/-76 vs W: 143+/-96 mm, p:O.O4). 
Mean follow-up pertod was 16.9+/-a months. Using Kaplan-Meier analaysis, one-year 
primary patency in the smart group was significantly higher compared to the wallstent 
group (S: 61+/-5% vs W: 30+/-5, p: 0.0000). One-year assisted primary patency 
increased lo 75+1-4% in the S group and 53+/-5% in the W group (p: 0.0000). Secondary 
patency at one-year was 79+/-4% in the S group vs. 64+/-5% in the W group (p: 0.007). 
Conclusion: - Stenting long SFA lesions with nitinol stents is associated wth a signifi- 
cantly better outcome comparing self-expandable stainless steel stents. 
- The long-term secondary patency of about 60% using nitinol stems demonstrates that 
this technology is safe, clinically very effectlve and comparable with reported surgical 
results. 
9:45 a.m. 
868-6 Renal Angioplasty and Stenting Under Distal Protection 
Michel Hew, lsabelle Henry, Christos Klonarls. Mich&le Hugel, I.L.R.M.D.T., Nancy, 
France 
Purpose: Renal arlery stenting is safe & efficient but at least 20% of the patients have a 
deterioration of the renal function after the procedure. We evaluate feasibility and safety 
of renal artery angioplasty and stenting using a distal protection device to reduce the risk 
of intraprocedural artery embolism and to avoid deterioration of the renal function. Yeth- 
ods: 46 Hypertensive patients (26 men ; mean age 67.7 + 6.3 years, range (22-67) with 
atherosclerotic renal artery stenosis (6 bilateral) underwent angioplasty & stenting with 
distal protection in 52 renal arteries (46 ostial lesions). 3 patients had solitary kidney, 15 
renal insufficiency. The lesion was crossed either with a Guard Wire temporary occlusion 
balloon (n=36). which was inflated lo provide parenchyma protection or with a filter (EPI 
Filter) fn=l31. Analoauard fn=l) which allow a continuous flow. Generated debris was _ _ 
aspirated and analyzed, blood pressure and serum creatinine levels followed. 
Results: Immediate technical success = 100 %. All lesions exceot 1 were stented. Visi- 
ble debris was aspirated with the Percusurge or removed with filters. Mean particle num- 
ber and diameter = 96.1 * 60.0 per procedure (range 13.206) and 201.2 * 76.0 %m 
(range 36.6206), respectively. Mean renal artery occlusion time = 6.55 * 2.46 mn (range 
2.29-13.21) with the Percusurge Device. Mean time in situ (filters): 4.2 * 1.1 mn. 
Mean follow-up = 23.6 * 14 months (range 1:42). Systolic and diastolic blood pressure 
declined from 169.0 -t 15.1 & 104.0 t 13.0 mm Hg, respectively, lo 149.6 f 12.3 & 92.6 f 
6.7 mm Hg after procedure. The mean cretonne level remains constant during the follow- 
up. At 6 month follow up (31 patients); renal function did not deteriorate in any patient, 
whereas 6 patients with baseline renal insufficiency improved after the procedure. At 3 
years (19 patients) renal function deteriorated only I” 1 patient with renal insufficiency. 
The renal function remains improved in 5 patients. 
Conclusion: These first results suggest the feasibility and safety of distal protection dur- 
ing renal interventions to protect against atheroembolism and to avoid renal function 
deterioration. The beneficial effects should be evaluated by randomized studies. 
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877-1 An Optimal Diagnostic Threshold of Minimum Stent 
Area to Predict Long-Term Stent Patency Following 
Sirolimus-Eluting Stent Implantation: Serial 
Intravascular Ultrasound Analysis From the SIRIUS 
Trial 
Shinio Sonoda, Yoshihiro Merino, Junya Ako, Ali Hassan, Mark Reisman, Shing C. 
Wong, Theodore A. Bass, Alan C. Yeung, Martin B. Leon, Jeffrey W. Moses, Paul G. 
Yock. Yasuhiro Honda, Peter J. Fitzgerald, the SIRIUS Investigators. Stanford Universtty 
Medical Center, Stanford, CA, Lenox Hill Hospital, New York, NY 
Mintmum stent area (MSA) is a consistent predictor of instent restenosis. In bare metal 
stents (BMS). however, its predictive value is still limited because of biologic variability in 
the restenosis process. The aim of this study was to examine the diagnostic value of 
MSA in prediction of long-term patency of drug-eluting stent (sirolimus-eluting stents, 
SES) implantation compared to BMS. 
Methods: From the SIRIUS trial, 126 (SES 74; BMS 52) cases with complete serial IV&IS 
(baseline and 6 months follow-up) were analysed. MSA at post-procedure and minimum 
lumen area (MLA) at follow-up were obtained. Based on previous physiology studies. 
adequate stent patency at follow-up was defined as MLA > 4.0 mm2. 
Results: In both groups, a significant positive correlation was observed between base- 
line MSA and follow-up MLA (SES: p~O.0001, BMS: pcO.0001). However, SES showed 
higher correlation than BMS (0.60 vs. 0.65) with a higher regression coefficient (0.92 vs. 
0.59). The sensitivity and specificity curves identified different optimal diagnostic thresh- 
olds of MSA for adequate follow-up MLA: 5.0 mn? for SES and 6.5 mm2 for BMS. The 
positive predictive values with these cut-off points were 90% and 56%, respectively. 
Conclusions: Based on the SIRIUS IVUS substudy, in SES, MSA is a stronger predictor 
of outcome than in BMS, due to the reduction of biologic variability. In addition. SES has 
a considerably lower optimal MSA threshold (5.0 mm2) compared to BMS (6.5 mm2). 
IO:45 a.m. 
877-2 Influence of Calcium on Neointimal Growth Following 
Drug-Eluting and Bare Metal Stents Implantation: A 3-D 
Intravascular Ultrasound Substudy of the SCORE Trial 
Tow Kataoka. Yoshihiro Merino, Brian K. Courtney, Rachna Basisht, Seung-Ho Hur, 
Paul G. Yock, Eberhard Grube, Peter J. Fitzgerald, Yasuhiro Honda, for the SCORE 
Investigators, Stanford University, Stanford, CA, Heart Center Siegburg, Siegburg, 
Germany 
Background: Plaque characteristics may affect pharmacokinetics of drug-eluting stents 
and. therefore. neointimal (NI) orowth suooression. The aim of this studv was to examine 
I _  
the potential influence of plaque calcium (CA) deposits on NI growth following 7.hex- 
anovltaxol-elutino stent (DES) and bare metal stent fBMSI imolantation. 
” ~ , 
Methods: In SCORE, complete 6.month follow-up 3D IVUS data were available in 41 
lesions (DES: 22, BMS: 19). Volume indices (volume/stent length) were computed for 
stem (SVI), lumen (LVI), and neointima (NVI). Lumen and stent contours were extracted 
from the dataset at 0.5 mm intervals over the stented segment. The contours were then 
exporied into custom-designed software lo compute mean NI thickness within 12 
equally-spaced radial sectors in each frame, referenced from the stem center (DES: 
6.040. BMS: 7.224 sectors). The oresence and location of CA deooslt (none: N. suoerfi- 
cial: S, deep: D) were also evaluated at each sector. 
Results: Overall. DES reduced NI orowth cornoared to BMS 10.3iO.3 mmslmm vs 
2.7el.6 mmslmm, pcO.0001). In BMS, larger NI growth was observed at non-calctfied 
plaque segments compared to those with superficial or deep CA. In contrast, with DES 
the NI growth suppression was comparable I” calcified and non-calcified segments (Fig- 
WC?). 
